Press Releases
All the latest news and press releases by Qubit Pharmaceuticals
.png?width=2000&height=1125&name=Velocity%20Jumps%20for%20MD%20(1).png)
Qubit Pharmaceuticals announces the appointment of Robin Chaudret as Chief Technology Officer
March 18, 2025
.jpg?width=2000&height=1125&name=Copy%20of%20Preprint%20Template%20(Blog%20Banner).jpg)
Qubit Pharmaceuticals selected to join Cité de l'Innovation Sorbonne Université
February 18, 2025

Qubit Pharmaceuticals nominated for "Best Startup 2024" award by Prix Galien USA
August 13, 2024
.png?width=1452&height=760&name=668e8808e51918445e9188a8_Conf%C3%A9rence%20de%20presse%20Qubit%20Pharmaceuticals%20%26Quantonation%20%26Scaleway%20(Facebook%20Ad).png)
Major breakthrough in quantum algorithms: Qubit Pharma and Sorbonne University drastically reduce the number of qubits needed to simulate molecules
July 10, 2024

Qubit Pharmaceuticals selected as one of the 100 Technology Pioneers 2024 by the World Economic Forum
June 6, 2024
.png?width=1200&height=627&name=65bd1333d8959883761275a9_Curie-Bordeaux-Qubit%20(1).png)
High-Performance Computing, simulations and AI: Qubit Pharmaceuticals, Institut Curie and the University of Bordeaux Join Forces to Advance the Development of Novel Cancer Therapies
January 30, 2024

Qubit Pharmaceuticals strengthens its commitment to DistriQ - Quantum Innovation Zone by partnering with the PINQ² platform in order to accelerate pharmaceutical research through quantum computing
July 10, 2024
.png?width=1200&height=627&name=65797ae8bb34d4e4c67a045f_Hyperion1%20-%20LinkedIn%20Article%20Illustration%20(3).png)
Qubit Pharmaceuticals and Sorbonne University achieve a major scientific breakthrough by simulating quantum calculations at more than 40 qubits on conventional computers
December 6, 2023
%20(1).jpg?width=2000&height=1125&name=Copy%20of%20Preprint%20Template%20(Blog%20Banner)%20(1).jpg)
Qubit Pharmaceuticals announces €4.5m
investment in a new drug discovery platform
targeting RNA as a therapeutic target
November 16, 2023

French start-ups Pasqal and Qubit Pharmaceuticals join with Unitary Fund to win Wellcome Trust's "Quantum for Bio" program
September 26, 2023